Search results
Results from the WOW.Com Content Network
It was established in 2002 [1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick. [ 2 ] According to the Journal Citation Reports , the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology" [ 3 ] and 1st out of 279 journals in the ...
The four journals cover developments across the breadth of therapeutic areas and technologies relevant to the drug discovery and development pipeline. However, as of 2022, these titles have been discontinued and incorporated back into Drug Discovery Today. According to the Journal Citation Reports, the journal has a 2022 impact factor of 8.2. [1]
Impact factor. 7.050 (2021) ... Journal homepage; Expert Opinion on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel ...
According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.495, ranking it 27th out of 59 journals in the category "Chemistry, Medicinal" [2] and 163 out of 289 journals in the category "Biochemistry & Molecular Biology". [3] The editor-in-chief is Mike Waring (Newcastle University). [4]
According to the Journal Citation Reports, the journal's 2016 impact factor is 2.444, ranking it 31 out of 76 journals in the "Chemistry, Analytical" category, [2] 67 out of 158 journals in the "Biotechnology & Applied Microbiology" category; [3] and 39 out of 77 journals in the "Biochemical Research Methods" category. [4]
Drug Discovery Today was ... The current set of Trends journals are all published monthly: Title ISO 4 abbreviation Field Editor Started Impact factor 2022 [1 ...
Drug Design, Development and Therapy; Drug Development and Industrial Pharmacy; Drug Discovery Today; Drug, Healthcare and Patient Safety; Drug Safety; Drug Metabolism Reviews; Drug Testing and Analysis; European Heart Journal - Cardiovascular Pharmacotherapy; European Journal of Pharmaceutical Sciences; European Journal of Pharmaceutics and ...
The Nature Partner Journals series, abbreviated npj, is a series of online-only, open access, journals. It was launched in April 2014 with three journals: npj Primary Care Respiratory Medicine, npj Biofilms and Microbiomes, and npj Schizophrenia.